DK1474690T3 - E2-forskydningsassay til identifikation af inhibitorer af HPV - Google Patents

E2-forskydningsassay til identifikation af inhibitorer af HPV

Info

Publication number: DK1474690T3
Authority: DK; Denmark
Prior art keywords: probe; signal; hpv; fluorescence; derivative
Prior art date: 2002-02-07

Inventor

Peter White

Christiane Yoakim

Original Assignee

Boehringer Ingelheim Ca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-07

Filing date

2003-02-04

Publication date

2011-01-10

2003-02-04Application filed by Boehringer Ingelheim Ca LtdfiledCriticalBoehringer Ingelheim Ca Ltd

2011-01-10Application grantedgrantedCritical

2011-01-10Publication of DK1474690T3publicationCriticalpatent/DK1474690T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
Pathology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Plural Heterocyclic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK03700788.7T2002-02-072003-02-04E2-forskydningsassay til identifikation af inhibitorer af HPVDK1474690T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US35571102P	2002-02-07	2002-02-07
PCT/CA2003/000155WO2003067259A1 (en)	2002-02-07	2003-02-04	E2 displacement assay for identifying inhibitors of hpv

Publications (1)

Publication Number	Publication Date
DK1474690T3true DK1474690T3 (da)	2011-01-10

Family

ID=27734553

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03700788.7TDK1474690T3 (da)	2002-02-07	2003-02-04	E2-forskydningsassay til identifikation af inhibitorer af HPV

Country Status (12)

Country	Link
US (1)	US6825176B2 (da)
EP (1)	EP1474690B1 (da)
JP (1)	JP2005517183A (da)
AT (1)	ATE484751T1 (da)
AU (1)	AU2003202390A1 (da)
CA (1)	CA2474205C (da)
DE (1)	DE60334524D1 (da)
DK (1)	DK1474690T3 (da)
ES (1)	ES2352332T3 (da)
MX (1)	MXPA04007705A (da)
NZ (1)	NZ535051A (da)
WO (1)	WO2003067259A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000001720A2 (en)*	1998-07-02	2000-01-13	President And Fellows Of Harvard College	Compositions and methods for treating papillomavirus-infected cells
US7914453B2 (en)	2000-12-28	2011-03-29	Ardent Sound, Inc.	Visual imaging system for ultrasonic probe
US7824348B2 (en)	2004-09-16	2010-11-02	Guided Therapy Systems, L.L.C.	System and method for variable depth ultrasound treatment
US8535228B2 (en)	2004-10-06	2013-09-17	Guided Therapy Systems, Llc	Method and system for noninvasive face lifts and deep tissue tightening
US10864385B2 (en)	2004-09-24	2020-12-15	Guided Therapy Systems, Llc	Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US8444562B2 (en)	2004-10-06	2013-05-21	Guided Therapy Systems, Llc	System and method for treating muscle, tendon, ligament and cartilage tissue
US20120165848A1 (en)	2010-08-02	2012-06-28	Guided Therapy Systems, Llc	System and method for treating cartilage
US7758524B2 (en)	2004-10-06	2010-07-20	Guided Therapy Systems, L.L.C.	Method and system for ultra-high frequency ultrasound treatment
US20060111744A1 (en)	2004-10-13	2006-05-25	Guided Therapy Systems, L.L.C.	Method and system for treatment of sweat glands
US8690779B2 (en)	2004-10-06	2014-04-08	Guided Therapy Systems, Llc	Noninvasive aesthetic treatment for tightening tissue
US8133180B2 (en)	2004-10-06	2012-03-13	Guided Therapy Systems, L.L.C.	Method and system for treating cellulite
US11883688B2 (en)	2004-10-06	2024-01-30	Guided Therapy Systems, Llc	Energy based fat reduction
US9694212B2 (en)	2004-10-06	2017-07-04	Guided Therapy Systems, Llc	Method and system for ultrasound treatment of skin
US11235179B2 (en)	2004-10-06	2022-02-01	Guided Therapy Systems, Llc	Energy based skin gland treatment
US9827449B2 (en)	2004-10-06	2017-11-28	Guided Therapy Systems, L.L.C.	Systems for treating skin laxity
US11207548B2 (en)	2004-10-07	2021-12-28	Guided Therapy Systems, L.L.C.	Ultrasound probe for treating skin laxity
US11724133B2 (en)	2004-10-07	2023-08-15	Guided Therapy Systems, Llc	Ultrasound probe for treatment of skin
WO2006116480A2 (en)	2005-04-25	2006-11-02	Guided Therapy Systems, L.L.C.	Method and system for enhancing computer peripheral saftey
US12102473B2 (en)	2008-06-06	2024-10-01	Ulthera, Inc.	Systems for ultrasound treatment
KR20110091832A (ko)	2008-06-06	2011-08-12	얼테라, 인크	조직 이미징 및 치료 시스템
CA2748362A1 (en)	2008-12-24	2010-07-01	Michael H. Slayton	Methods and systems for fat reduction and/or cellulite treatment
US8715186B2 (en)	2009-11-24	2014-05-06	Guided Therapy Systems, Llc	Methods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US9504446B2 (en)	2010-08-02	2016-11-29	Guided Therapy Systems, Llc	Systems and methods for coupling an ultrasound source to tissue
US20130012816A1 (en)	2011-07-10	2013-01-10	Guided Therapy Systems, Llc	Methods and systems for controlling acoustic energy deposition into a medium
WO2013012641A1 (en)	2011-07-11	2013-01-24	Guided Therapy Systems, Llc	Systems and methods for coupling an ultrasound source to tissue
US9263663B2 (en)	2012-04-13	2016-02-16	Ardent Sound, Inc.	Method of making thick film transducer arrays
US9510802B2 (en)	2012-09-21	2016-12-06	Guided Therapy Systems, Llc	Reflective ultrasound technology for dermatological treatments
CN104027893B (zh)	2013-03-08	2021-08-31	奥赛拉公司	用于多焦点超声治疗的装置和方法
WO2014146022A2 (en)	2013-03-15	2014-09-18	Guided Therapy Systems Llc	Ultrasound treatment device and methods of use
CN103342686B (zh)*	2013-07-02	2015-01-14	扬州大学	2-苯亚甲基-1,3-茚满二酮双键的环氧化新方法
WO2015160708A1 (en)	2014-04-18	2015-10-22	Ulthera, Inc.	Band transducer ultrasound therapy
CN104151326B (zh)*	2014-08-14	2016-04-27	东南大学	一种苝二酰亚胺-罗丹明荧光探针及其制备方法和应用
CN104817564B (zh)*	2015-03-31	2017-03-22	东南大学	一种罗丹明‑(4‑二甲基氨乙基氨基‑1,8‑萘二甲酰亚胺)荧光分子及其制备方法和应用
ES2939604T3 (es)	2016-01-18	2023-04-25	Ulthera Inc	Dispositivo de ultrasonidos compacto que tiene una matriz de ultrasonidos anular conectada eléctricamente de manera periférica a una placa de circuito impreso flexible
PL3981466T3 (pl)	2016-08-16	2023-11-20	Ulthera, Inc.	Układy i sposoby dla ultradźwiękowych zabiegów kosmetycznych na skórze
TWI797235B (zh)	2018-01-26	2023-04-01	美商奧賽拉公司	用於多個維度中的同時多聚焦超音治療的系統和方法
US11944849B2 (en)	2018-02-20	2024-04-02	Ulthera, Inc.	Systems and methods for combined cosmetic treatment of cellulite with ultrasound
US12377293B2 (en)	2019-07-15	2025-08-05	Ulthera, Inc.	Systems and methods for measuring elasticity with imaging of ultrasound multi-focus shearwaves in multiple dimensions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5464936A (en)*	1990-12-21	1995-11-07	Cetus Oncology Corporation	Compositions for identification of papillomavirus replication inhibitors
US6960429B2 (en)*	1997-11-12	2005-11-01	Wisconsin Alumni Research Foundation	Inhibition of viral gene activities
MXPA03005479A (es)*	2000-12-18	2004-05-31	Boehringer Ingelheim Ca Ltd	Inhibidores del virus de papiloma.

2003
- 2003-02-04DKDK03700788.7Tpatent/DK1474690T3/daactive
- 2003-02-04WOPCT/CA2003/000155patent/WO2003067259A1/enactiveApplication Filing
- 2003-02-04AUAU2003202390Apatent/AU2003202390A1/ennot_activeAbandoned
- 2003-02-04MXMXPA04007705Apatent/MXPA04007705A/esnot_activeApplication Discontinuation
- 2003-02-04EPEP03700788Apatent/EP1474690B1/ennot_activeExpired - Lifetime
- 2003-02-04CACA002474205Apatent/CA2474205C/ennot_activeExpired - Fee Related
- 2003-02-04ATAT03700788Tpatent/ATE484751T1/deactive
- 2003-02-04NZNZ535051Apatent/NZ535051A/enunknown
- 2003-02-04ESES03700788Tpatent/ES2352332T3/esnot_activeExpired - Lifetime
- 2003-02-04JPJP2003566558Apatent/JP2005517183A/jaactivePending
- 2003-02-04DEDE60334524Tpatent/DE60334524D1/denot_activeExpired - Lifetime
- 2003-02-05USUS10/358,790patent/US6825176B2/ennot_activeExpired - Lifetime

Also Published As

Publication number	Publication date
EP1474690B1 (en)	2010-10-13
JP2005517183A (ja)	2005-06-09
US20030194698A1 (en)	2003-10-16
ATE484751T1 (de)	2010-10-15
US6825176B2 (en)	2004-11-30
CA2474205C (en)	2009-06-02
NZ535051A (en)	2006-04-28
EP1474690A1 (en)	2004-11-10
DE60334524D1 (de)	2010-11-25
MXPA04007705A (es)	2005-07-13
ES2352332T3 (es)	2011-02-17
WO2003067259A1 (en)	2003-08-14
CA2474205A1 (en)	2003-08-14
AU2003202390A1 (en)	2003-09-02

Publication	Publication Date	Title
DK1474690T3 (da)	2011-01-10	E2-forskydningsassay til identifikation af inhibitorer af HPV
ATE475095T1 (de)	2010-08-15	Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren
JP2004503760A5 (da)	2005-04-07
EP2253688A3 (de)	2011-04-06	Kalibriereinrichtung und Farbstoffkit sowie ihre Verwendungen zur Charakterisierung von Lumineszenzmesssystemen
ATE556323T1 (de)	2012-05-15	Neurofibrilläre marker
CY1107660T1 (el)	2013-04-18	Μεθοδοι επισημανσης υλικων
IL180208A0 (en)	2007-07-04	Methods and reagents for the detection of melanoma
DE60335428D1 (de)	2011-02-03	Immunogene, Antikörper und Konjugate für Ketamin und dessen Metaboliten
ATE516363T1 (de)	2011-07-15	Generischer kinase-/phosphatasetest mit einzelablesung
ATE458826T1 (de)	2010-03-15	Verfahren zur bestimmung von keimen
DE60120460D1 (de)	2006-07-20	Teststab
DE69900465D1 (de)	2001-12-20	Ein screeningverfahren, basierend auf fluoreszenzpolarisation
WO2006020933A3 (en)	2009-03-19	Dual labeled fluorescent probes
CY1114785T1 (el)	2016-12-14	Ανιχνευση και καταμετρηση μικροοργανισμων
DE602004017884D1 (de)	2009-01-02	Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
WO2005030979A3 (en)	2005-07-21	Dark quenchers for fluorescence resonance energy transfer (fret) in bioassays
ATE500505T1 (de)	2011-03-15	Enzymhemmungsimmunverfahren
ATE466284T1 (de)	2010-05-15	Bakterientestverfahren mit bindung einer intrazellularer enzyme
ATE540048T1 (de)	2012-01-15	Neurotransmittersensoren und verfahren zu ihrer verwendung
WO2001002598A3 (en)	2001-05-31	Screening for compounds modulating mitochondrial proton leak
DE602006013361D1 (de)	2010-05-12	Verfahren zum on-site-drogennachweis bei illegalen drogenproben
DE602005022994D1 (de)	2010-09-30	Assays für amphetamin und methamphetamin
DK1415006T3 (da)	2007-09-10	Assay til identifikation af inhibitorer af HIV RT-dimerisering
JP2001512032A5 (da)	2006-01-05
WO2005058865A3 (en)	2005-08-04	Assay for entactogens

Movatterモバイル変換